(Press-News.org) The Krantz Family Center for Cancer Research at the Mass General Cancer Center today announced the selection of 17 scientists who have been awarded a combined $6 million in funding. These competitive awards, which will be granted annually, were established to recognize the trailblazing efforts of Krantz Center scientists and accelerate ideas, projects and initiatives with the potential to fundamentally change how cancer is diagnosed and treated.
Philanthropists Jason and Keely Krantz, who in September of 2023 made the largest research-directed gift in the Mass General Cancer Center’s 34-year history, included annual funding for innovative and collaborative research projects, advanced technologies to support cancer research, and an endowment to ensure sustainability. The awards announced today reflect the Krantz Center’s commitment to supporting cutting-edge research.
The awards are distributed to individual investigators and research teams at the Krantz Center in four tiers: Quantum Awards (with up to $2 million in funding to support research with the potential to transform overall understanding and treatment of cancer); Breakthrough Awards (with up to $1 million for projects that accelerate the most promising scientific concepts); Spark Awards (with up to $100,000 to test exciting new thought-provoking ideas); and Technology Support (to provide for the purchase of cutting-edge equipment and technological innovation).
The inaugural recipients were determined through a rigorous selection process that included internal and external scientific review. The final decisions were based on the individual project’s ability to have outsized impact on the future of cancer care and treatment. The number of awards presented each year will be dependent upon the diversity and merit of the proposals submitted.
“The Krantz Center for Cancer Research is home to some of the world’s most innovative and creative cancer investigators,” said Jason Krantz, founder, CEO and executive chairman of Definitive Healthcare. “These elite researchers come to Mass General because they want to be involved in the game-changing research that they believe can truly transform cancer care here in Massachusetts and around the globe. The Krantz Awards are designed to accelerate this work with the goal of bringing lifesaving therapies and diagnostics to cancer patients everywhere as quickly as possible.”
2023 Krantz Award Recipients
The Quantum Award was presented to the team of Liron Bar-Peled, PhD, Michael Lawrence, PhD, and Chris Ott, PhD. The team will receive $2 million over two years to explore new chemical-proteomic technologies to target transcription factors, a type of protein that can act as a genetic driver of cancer. Transcription factors are considered “undruggable” with current therapies. If their collaborative work is successful, Drs. Bar-Peled, Lawrence and Ott — who each oversee their own individual labs in the Krantz Center — could help usher in a new class of cancer therapeutics.
The following teams were selected to receive Breakthrough Awards, which include $1 million per team over two years:
Max Jan MD, PhD, Robert Manguso, PhD, Marcela Maus MD, PhD, and Debattama Sen PhD, are working to optimize CAR T-cell immunotherapy by improving the technology’s ability to kill cancer cells, reducing treatment failure (so-called CAR T-cell “exhaustion”), and developing ways to prevent side effects and toxicity.
Genevieve Boland MD, PhD, Russ Jenkins MD, PhD and Moshe Sade-Feldman, PhD, are using a combination of surgical expertise, in vitro culture technologies and molecular sequencing to identify optimal strategies for using adoptive T-cell therapy, a promising immunotherapy approach utilizing the body’s natural tumor-seeking immune cells.
Nabeel Bardeesy, PhD, and Raul Mostoslavsky, MD, PhD, are exploring if targeting the genes that control cancer cell metabolism can be used to suppress the disease.
The following scientists were selected to receive Spark Awards, which include $100,000 in funding per recipient:
Andrew Elia, MD, PhD, to study the role of DNA damage pathways within immune cells.
Gad Getz, PhD, to develop a deep learning molecular language model for cancer drug discovery.
Abner Louissaint, MD, PhD to create and test models of patient-derived lymphomas.
Mo Motamedi, PhD, to explore chromatin regulation in combination with cancer chemotherapy.
Shannon Stott, PhD, to study non-invasive blood testing for immunotherapy complications.
In addition to the research-focused awards, the Krantz family also established a Technology Support Fund. This year’s awards include funds to support the purchase of advanced microscopy, flow cytometry, real time cell culture technologies and high content imaging data handling.
“Much remains to be done in understanding the fundamental biology that drives different types of cancer, and the dozen inaugural awards will empower new initiatives from some of our most talented faculty working together on collaborative projects,” said Daniel Haber, MD, PhD, director of the Mass General Cancer Center and the Krantz Family Center for Cancer Research. “Research projects that are launched at the Krantz Center will ultimately translate into better ways to treat and prevent cancer.”
Additional information about the awardees and their research can be found here:
www.massgeneral.org/cancer-center/clinical-trials-and-research/center-for-cancer-research/krantz-awards/2023
About the Krantz Family Center for Cancer Research
With 50 independent laboratory-based faculty members with appointments across different departments at Mass General and Harvard Medical School, and more than 500 postdoctoral fellows, graduate students, trainees and technicians, the Krantz Family Center for Cancer Research is home to some of the brightest scientific minds all focused on one goal: understanding the fundamental biology that drives cancer and applying that knowledge toward its eradication. Investigators have established an international reputation for scientific excellence, and for collaborative partnerships that bridge from basic research to patient care.
About Mass General Brigham
Mass General Brigham is an integrated academic health care system, uniting great minds to solve the hardest problems in medicine for our communities and the world. Mass General Brigham connects a full continuum of care across a system of academic medical centers, community and specialty hospitals, a health insurance plan, physician networks, community health centers, home care, and long-term care services. Mass General Brigham is a nonprofit organization committed to patient care, research, teaching, and service to the community. In addition, Mass General Brigham is one of the nation’s leading biomedical research organizations with several Harvard Medical School teaching hospitals. For more information, please visit massgeneralbrigham.org.
END
Mass General Cancer Center announces first recipients of Krantz Awards for Cancer Research
The inaugural class of awardees will receive more than $6 million in funding to accelerate groundbreaking cancer research.
2024-01-24
ELSE PRESS RELEASES FROM THIS DATE:
A large percentage of European plastic sent to Vietnam ends up in nature
2024-01-24
Despite strict EU regulations on plastic recycling, there is little oversight on plastic waste shipped from the EU to Vietnam. A large percentage of the exported European plastic cannot be recycled and gets dumped in nature. That is what new research led by Utrecht University’s Kaustubh Thapa has found.
Following the recycling path
About half of Europe’s plastic waste is exported to a number of countries in the Global South, including Vietnam. A Dutch and Vietnamese research team ventured to Minh Khai Craft Village, the largest recycling hub ...
A year of breakthroughs from Cincinnati Children’s
2024-01-24
Cincinnati Children’s continues to be a cradle for great discoveries.
Our latest Research Annual Report, online now, recounts a remarkable year of scientific advancement supported by a record-high level of research funding from federal, state, industry and philanthropic sources.
Among the many accomplishments from more than 1,000 faculty working in 50 research areas:
Promising results from the world’s first clinical trial of FLASH proton therapy for cancer treatment
Developing the first intestine organoids with functional immune cells, a major step closer to testing potential treatments using these amazing lab-grown tissues
Completing ...
AMS Science Preview: The “Black Swan” heatwave; volcanic chillers; tornadogenesis
2024-01-24
The American Meteorological Society continuously publishes research on climate, weather, and water in its 12 journals. Many of these articles are available for early online access–they are peer-reviewed, but not yet in their final published form.
Below is a selection of articles published early online recently. To view full article text, members of the media can contact kpflaumer@ametsoc.org for press login credentials.
Searching for the Most Extreme Temperature Events in Recent History
Bulletin ...
Ultrasounds can help predict the risk of preterm births, new research shows
2024-01-24
Researchers have developed a way to use ultrasound to predict whether a pregnant person is at risk of delivering a baby prematurely, which occurs in upward of 10% of pregnancies in the U.S.
The new method — the result of more than 20 years of collaboration between researchers in nursing and engineering at University of Illinois Chicago and University of Illinois Urbana-Champaign — measures microstructural changes in a woman’s cervix using quantitative ultrasound. The ultrasound method works as early as 23 weeks into a pregnancy, according to the research, which is published in ...
Exposure to flame retardants linked to premature birth, higher birth weight
2024-01-24
(SACRAMENTO, Calif.) — In the largest study of its kind, researchers at UC Davis Health found that exposure to organophosphate ester flame retardants during pregnancy was associated with preterm birth, especially among females. The chemicals were also linked to higher birth weight, a concern for increased obesity risk. The major new research study was published in Environmental Health Perspectives.
“The importance of this study lies in unraveling the potential impact of exposure to environmental chemicals during pregnancy on fetal development. Our findings guide our understanding of how these chemicals may be silently seeding lasting challenges ...
How a protein fights off bacteria
2024-01-24
The human immune system is constantly fending off a wide range of invaders – a feat that requires a diverse array of cellular troops and molecular weaponry. Although a great deal is already known about immune defense cells and the strategies they employ, many molecular details have remained elusive. Now a research team led by Professor Oliver Daumke, a lab head at the Max Delbrück Center, has managed to unravel the main activation mechanism of GBP1, a protein that plays a pivotal role in combating certain bacteria. They report in “The EMBO ...
Breakthrough technology offers promising treatment for ischemic retinopathy
2024-01-24
A groundbreaking technology with immense potential in treating ischemic retinopathy in premature infants and diabetic patients has been developed by Professor Byoung Heon Kang and his research team in the Department of Biological Sciences at UNIST, in collaboration with Professor Dong Ho Park’s team at Kyungpook National University Hospital. Ischemic retinopathy, characterized by the breakdown of the blood-retinal barrier and abnormal blood vessel growth, often leads to vision impairment and loss. The researchers have identified the critical role of a mitochondrial ...
Death rate higher than expected for patients with functional, nonepileptic seizures
2024-01-24
The death rate for patients with functional, nonepileptic seizures is higher than expected, with a rate comparable to epilepsy and severe mental illness, a Michigan Medicine-led study finds.
A team of researchers reviewed data from 700 patients who were diagnosed with functional seizures, also called psychogenic or nonepileptic seizures, between 2014 and mid-2023 and followed for a median of 15 months.
It is the largest study of its kind in the United States, matching international studies in Australia, Denmark, Sweden and the United Kingdom, all of which have nationalized health care systems.
Of the 700 patients with functional ...
National Science Foundation and The Kavli Foundation partner on call for research proposals in neurobiology and changing ecosystems
2024-01-24
The Kavli Foundation and the U.S. National Science Foundation (NSF) Directorate for Biological Sciences' Division for Integrative Organismal Systems have joined forces to launch a grant program in neurobiology and changing ecosystems. Research in this emerging field has great potential to reveal novel scientific insights that will accelerate understanding of basic biology in neural adaptation and resilience at the molecular, biophysical, cellular, and circuit levels.
“NSF’s partnership with The Kavli Foundation will enable the U.S. to advance research in this emerging and understudied field,” remarked Denise Dearing, Division ...
Facial recognition app for dogs developed to help in fight against rabies
2024-01-24
A new mobile phone-based facial recognition application for dogs has the potential to significantly improve rabies vaccination efforts in endemic areas like Africa and Asia, according to a study on the research published in the journal Scientific Reports.
Led by researchers at Washington State University, a team used the app to test its effectiveness at a rabies vaccination clinic in rural Tanzania where they microchipped, vaccinated and registered dogs. The technology proved remarkably accurate during a subsequent visit to surrounding villages once poor images and improperly recorded ...
LAST 30 PRESS RELEASES:
Bioeconomy in Colombia: The race to save Colombia's vital shellfish
NFL’s Colts bring CPR education to flag football to improve cardiac emergency outcomes
Research: Fitness more important than fatness for a lower risk of premature death
Researchers use biophysics to design new vaccines against RSV and related respiratory viruses
New study highlights physician perspectives on emerging anti-amyloid treatments for Alzheimer’s disease in Israel
U of M research finds creativity camp improves adolescent mental health, well-being
How human brain functional networks emerge and develop during the birth transition
Low-dose ketamine shows promise for pain relief in emergency department patients
Lifestyle & risk factor changes improved AFib symptoms, not burden, over standard care
Researchers discover new cognitive blueprint for making and breaking habits
In a small international trial, novel oral medication muvalaplin lowered Lp(a)
Eradivir’s EV25 therapeutic proven to reduce advanced-stage influenza viral loads faster, more thoroughly in preclinical studies than current therapies
Most Medicare beneficiaries do not compare prescription drug plans – and may be sticking with bad plans
“What Would They Say?” video wins second place in international award for tobacco control advocacy
Black Britons from top backgrounds up to three times more likely to be downwardly mobile
Developing an antibody to combat age-related muscle atrophy
Brain aging and Alzheimer's: Insights from non-human primates
Can cells ‘learn’ like brains?
How cells get used to the familiar
Seemingly “broken” genes in coronaviruses may be essential for viral survival
Improving hurricane modeling with physics-informed machine learning
Seed slippage: Champati cha-cha
Hospitalization following outpatient diagnosis of RSV in adults
Beyond backlash: how feeling threatened by diversity can trigger positive change
Climate change exposure associated with increased emergency imaging
Incorrect AI advice influences diagnostic decisions
Building roots in glass, a bio-inspired approach to creating 3D microvascular networks using plants and fungi
Spinning fusion fuel for efficiency
The American Pediatric Society names Dr. Beth Tarini as the recipient of the 2025 Norman J. Siegel New Member Outstanding Science Award
New Clinical Study Confirms the Anti-Obesity Effects of Kimchi
[Press-News.org] Mass General Cancer Center announces first recipients of Krantz Awards for Cancer ResearchThe inaugural class of awardees will receive more than $6 million in funding to accelerate groundbreaking cancer research.